Quantitative proteomic analyses of cerebrospinal fluid using itraq in a primate model of iron deficiency anemia

Developmental Neuroscience

Volumn 34, Issue 4, 2012, Pages 354-365

  Patton, Stephanie M ^a,c   Coe, Christopher L ^b   Lubach, Gabriele R ^b   Connor, James R ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

1 Antitrypsin; Amyloid A4 protein; Anemia; Cerebrospinal fluid; Fibronectin; Monkey; Prostaglandin H2 D isomerase; Toll like receptor 8

Indexed keywords

ITRAQ; REAGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN GROWTH; CELL MIGRATION; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; DISEASE MODEL; FEMALE; GENE EXPRESSION; IRON DEFICIENCY ANEMIA; IRON INTAKE; NERVE CELL; NERVE FIBER GROWTH; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; QUANTITATIVE ANALYSIS; RHESUS MONKEY; STATISTICAL SIGNIFICANCE; SYNAPSE; WEANING;

AGE FACTORS; ANEMIA, IRON-DEFICIENCY; ANIMALS; BRAIN DAMAGE, CHRONIC; CATION EXCHANGE RESINS; CEREBROSPINAL FLUID PROTEINS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, ION EXCHANGE; FEMALE; FERROUS COMPOUNDS; FOOD, FORTIFIED; MACACA MULATTA; MALE; MALNUTRITION; MODELS, ANIMAL; NERVE TISSUE PROTEINS; PEPTIDE FRAGMENTS; PREGNANCY; PREGNANCY COMPLICATIONS; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; WEANING;

EID: 84867993283     PISSN: 03785866     EISSN: 14219859     Source Type: Journal    
DOI: 10.1159/000341919     Document Type: Article

References (80)

1. Stoltzfus RJ, Dreyfuss ML, Chwaya HM, Albonico M: Hookworm control as a strategy to prevent iron deficiency. Nutr Rev 1997; 55: 223-232. (Pubitemid 27384880)
2. Looker AC, Dallman PR, Carroll MD, Gunter EW, Johnson CL: Prevalence of iron deficiency in the United States. JAMA 1997; 277: 973-976. (Pubitemid 27142364)
3. McLoyd VC: Socioeconomic disadvantage and child development. Am Psychol 1998; 53: 185-204. (Pubitemid 128455442)
4. Cusick SE, Mei Z, Freedman DS, Looker AC, Ogden CL, Gunter E, Cogswell ME: Unexplained decline in the prevalence of anemia among US children and women between 1988-1994 and 1999-2002. Am J Clin Nutr 2008; 88: 1611-1617.
5. Lozoff B: Iron deficiency and child development. Food Nutr Bull 2007; 28:S560-S571. (Pubitemid 351149506)
6. Lozoff B, Wolf AW, Jimenez E: Iron-deficiency anemia and infant development: effects of extended oral iron therapy. J Pediatr 1996; 129: 382-389. (Pubitemid 27484144)
7. Lozoff B, Georgieff MK: Iron deficiency and brain development. Semin Pediatr Neurol 2006; 13: 158-165. (Pubitemid 44712046)
8. Lozoff B, Jimenez E, Hagen J, Mollen E, Wolf AW: Poorer behavioral and developmental outcome more than 10 years after treatment for iron deficiency in infancy. Pediatrics 2000; 105:E51.
9. Coe CL, Lubach GR, Bianco L, Beard JL: A history of iron deficiency anemia during infancy alters brain monoamine activity later in juvenile monkeys. Dev Psychobiol 2009; 51: 301-309.
10. Jorgenson LA, Wobken JD, Georgieff MK: Perinatal iron deficiency alters apical dendritic growth in hippocampal CA1 pyramidal neurons. Dev Neurosci 2003; 25: 412-420. (Pubitemid 38250494)
11. Ward KL, Tkac I, Jing Y, Felt B, Beard J, Connor J, Schallert T, Georgieff MK, Rao R: Gestational and lactational iron deficiency alters the developing striatal metabolome and associated behaviors in young rats. J Nutr 2007; 137: 1043-1049. (Pubitemid 46596907)
12. Rao R, Tkac I, Townsend EL, Gruetter R, Georgieff MK: Perinatal iron deficiency alters the neurochemical profile of the developing rat hippocampus. J Nutr 2003; 133: 3215-3221. (Pubitemid 37222244)
13. Beard J: Iron deficiency alters brain development and functioning. J Nutr 2003; 133: 1468S-1472S. (Pubitemid 36548728)
14. Ortiz E, Pasquini JM, Thompson K, Felt B, Butkus G, Beard J, Connor JR: Effect of manipulation of iron storage, transport, or availability on myelin composition and brain iron content in three different animal models. J Neurosci Res 2004; 77: 681-689. (Pubitemid 39194609)
15. Borel MJ, Beard JL, Farrell PA: Hepatic glucose production and insulin sensitivity and responsiveness in iron-deficient anemic rats. Am J Physiol 1993; 264:E380-E390. (Pubitemid 23103950)
16. de Deungria M, Rao R, Wobken JD, Luciana M, Nelson CA, Georgieff MK: Perinatal iron deficiency decreases cytochrome c oxidase (CytOx) activity in selected regions of neonatal rat brain. Pediatr Res 2000; 48: 169-176. (Pubitemid 30497333)
17. Carlson ES, Fretham SJ, Unger E, O'Connor M, Petryk A, Schallert T, Rao R, Tkac I, Georgieff MK: Hippocampus specific iron deficiency alters competition and cooperation between developing memory systems. J Neurodev Disord 2010; 2: 133-143.
18. Tkac I, Rao R, Georgieff MK, Gruetter R: Developmental and regional changes in the neurochemical profile of the rat brain determined by in vivo 1H NMR spectroscopy. Magn Reson Med 2003; 50: 24-32. (Pubitemid 36841856)
19. Geguchadze RN, Coe CL, Lubach GR, Clardy TW, Beard JL, Connor JR: CSF proteomic analysis reveals persistent iron deficiency-induced alterations in non-human primate infants. J Neurochem 2008; 105: 127-136. (Pubitemid 351441629)
20. Thompson EJ: Cerebrospinal Fluid: CSF Proteins and Their Relevance in Research, Diagnostics and treatment. London, Elsevier Academic Press, 2004.
21. Yuan X, Russell T, Wood G, Desiderio DM: Analysis of the human lumbar cerebrospinal fluid proteome. Electrophoresis 2002; 23: 1185-1196.
22. Reyes TM, Coe CL: The proinflammatory cytokine network: interactions in the CNS and blood of rhesus monkeys. Am J Physiol 1998; 274:R139-R144.
23. Lubach GR, Coe CL: Preconception maternal iron status is a risk factor for iron deficiency in infant rhesus monkeys (Macaca mulatta). J Nutr 2006; 136: 2345-2349. (Pubitemid 44329993)
24. Bicknese EJ, George JW, Hird DW, Paul-Murphy J, Anderson JA, Roberts JR: Prevalence and risk factors for iron deficiency anemia in weanling rhesus macaques. Lab Anim Sci 1993; 43: 434-438. (Pubitemid 23352572)
25. Kriete MF, Champoux M, Suomi SJ: Development of iron deficiency anemia in infant rhesus macaques. Lab Anim Sci 1995; 45: 15-21.
26. Ogata Y, Charlesworth MC, Higgins L, Keegan BM, Vernino S, Muddiman DC: Differential protein expression in male and female human lumbar cerebrospinal fluid using iTRAQ reagents after abundant protein depletion. Proteomics 2007; 7: 3726-3734. (Pubitemid 350022278)
27. Tang WH, Shilov IV, Seymour SL: Nonlinear fitting method for determining local false discovery rates from decoy database searches. J Proteome Res 2008; 7: 3661-3667.
28. Corapci F, Calatroni A, Kaciroti N, Jimenez E, Lozoff B: Longitudinal evaluation of externalizing and internalizing behavior problems following iron deficiency in infancy. J Pediatr Psychol 2010; 35: 296-305.
29. Lukowski AF, Koss M, Burden MJ, Jonides J, Nelson CA, Kaciroti N, Jimenez E, Lozoff B: Iron deficiency in infancy and neurocognitive functioning at 19 years: evidence of longterm deficits in executive function and recognition memory. Nutr Neurosci 2010; 13: 54-70.
30. Wenner BR, Lovell MA, Lynn BC: Proteomic analysis of human ventricular cerebrospinal fluid from neurologically normal, elderly subjects using two-dimensional LC-MS/MS. J Proteome Res 2004; 3: 97-103. (Pubitemid 38233456)
31. Zougman A, Pilch B, Podtelejnikov A, Kiehntopf M, Schnabel C, Kumar C, Mann M: Integrated analysis of the cerebrospinal fluid peptidome and proteome. J Proteome Res 2008; 7: 386-399. (Pubitemid 351171153)
32. Schutzer SE, Liu T, Natelson BH, Angel TE, Schepmoes AA, Purvine SO, Hixson KK, Lipton MS, Camp DG, Coyle PK, Smith RD, Bergquist J: Establishing the proteome of normal human cerebrospinal fluid. PLoS One 2010; 5:e10980.
33. Rozek W, Ricardo-Dukelow M, Holloway S, Gendelman HE, Wojna V, Melendez LM, Ciborowski P: Cerebrospinal fluid proteomic profiling of HIV-1-infected patients with cognitive impairment. J Proteome Res 2007; 6: 4189-4199. (Pubitemid 350158497)
34. Wikoff WR, Pendyala G, Siuzdak G, Fox HS: Metabolomic analysis of the cerebrospinal fluid reveals changes in phospholipase expression in the CNS of SIV-infected macaques. J Clin Invest 2008; 118: 2661-2669. (Pubitemid 351949793)
35. Kwik-Uribe CL, Golubt MS, Keen CL: Behavioral consequences of marginal iron deficiency during development in a murine model. Neurotoxicol Teratol 1999; 21: 661-672. (Pubitemid 29494955)
36. Kwik-Uribe CL, Gietzen D, German JB, Golub MS, Keen CL: Chronic marginal iron intakes during early development in mice result in persistent changes in dopamine metabolism and myelin composition. J Nutr 2000; 130: 2821-2830.
37. Kwik-Uribe CL, Golub MS, Keen CL: Chronic marginal iron intakes during early development in mice alter brain iron concentrations and behavior despite postnatal iron supplementation. J Nutr 2000; 130: 2040-2048. (Pubitemid 30497542)
38. Youdim MB, Green AR: Iron deficiency and neurotransmitter synthesis and function. Proc Nutr Soc 1978; 37: 173-179.
39. Dallman PR: Biochemical basis for the manifestations of iron deficiency. Annu Rev Nutr 1986; 6: 13-40.
40. Beard J, Erikson KM, Jones BC: Neonatal iron deficiency results in irreversible changes in dopamine function in rats. J Nutr 2003; 133: 1174-1179. (Pubitemid 36407145)
41. Rao R, Tkac I, Schmidt AT, Georgieff MK: Fetal and neonatal iron deficiency causes volume loss and alters the neurochemical profile of the adult rat hippocampus. Nutr Neurosci 2011; 14: 59-65.
42. Felt BT, Beard JL, Schallert T, Shao J, Aldridge JW, Connor JR, Georgieff MK, Lozoff B: Persistent neurochemical and behavioral abnormalities in adulthood despite early iron supplementation for perinatal iron deficiency anemia in rats. Behav Brain Res 2006; 171: 261-270. (Pubitemid 43946501)
43. Golub MS: Recent studies of iron deficiency during brain development in nonhuman primates. Biofactors 2010; 36: 111-116.
44. Lubach GR, Coe CL: Selective impairment of cognitive performance in the young monkey following recovery from iron deficiency. J Dev Behav Pediatr 2008; 29: 11-17. (Pubitemid 351640534)
45. Urade Y, Hayaishi O: Prostaglandin D synthase: structure and function. Vitam Horm 2000; 58: 89-120.
46. Urade Y, Hayaishi O: Prostaglandin D(2) and sleep/wake regulation. Sleep Med Rev 2011; 15: 411-418.
47. Durmer JS, Dinges DF: Neurocognitive consequences of sleep deprivation. Semin Neurol 2005; 25: 117-129. (Pubitemid 40471632)
48. Jones K, Harrison Y: Frontal lobe function, sleep loss and fragmented sleep. Sleep Med Rev 2001; 5: 463-475. (Pubitemid 34066251)
49. Walker MP: Cognitive consequences of sleep and sleep loss. Sleep Med 2008; 9(suppl 1): S29-S34.
50. Janciauskiene SM, Bals R, Koczulla R, Vogelmeier C, Kohnlein T, Welte T: The discovery of alpha1-antitrypsin and its role in health and disease. Respir Med 2011; 105: 1129-1139.
51. de Serres FJ: Alpha-1 antitrypsin deficiency is not a rare disease but a disease that is rarely diagnosed. Environ Health Perspect 2003; 111: 1851-1854.
52. Hersh CP, Dahl M, Ly NP, Berkey CS, Nordestgaard BG, Silverman EK: Chronic obstructive pulmonary disease in alpha1-antitrypsin PI MZ heterozygotes: a meta-analysis. Thorax 2004; 59: 843-849. (Pubitemid 39389623)
53. Scott BB, Egner W: Does alpha1-antitrypsin phenotype PiMZ increase the risk of fibrosis in liver disease due to hepatitis C virus infection? Eur J Gastroenterol Hepatol 2006; 18: 521-523. (Pubitemid 43832752)
54. Perlmutter DH: Pathogenesis of chronic liver injury and hepatocellular carcinoma in alpha-1-antitrypsin deficiency. Pediatr Res 2006; 60: 233-238. (Pubitemid 44297600)
55. Schmechel DE, Browndyke J, Ghio A: Strategies for dissecting genetic-environmental interactions in neurodegenerative disorders. Neurotoxicology 2006; 27: 637-657. (Pubitemid 44232993)
56. Schmechel DE: Art, alpha-1-antitrypsin polymorphisms and intense creative energy: blessing or curse? Neurotoxicology 2007; 28: 899-914. (Pubitemid 47519798)
57. Weiss G, Graziadel I, Urbanek M, Grunewald K, Vogel W: Divergent effects of alpha 1-antitrypsin on the regulation of iron metabolism in human erythroleukaemic (K562) and myelomonocytic (THP-1) cells. Biochem J 1996; 319: 897-902. (Pubitemid 26386206)
58. Pandur E, Nagy J, Poor VS, Sarnyai A, Huszar A, Miseta A, Sipos K: Alpha-1 antitrypsin binds preprohepcidin intracellularly and prohepcidin in the serum. FEBS J 2009; 276: 2012-2021.
59. Hoffmann JA: The immune response of Drosophila. Nature 2003; 426: 33-38. (Pubitemid 37432534)
60. Ma Y, Li J, Chiu I, Wang Y, Sloane JA, Lu J, Kosaras B, Sidman RL, Volpe JJ, Vartanian T: Toll-like receptor 8 functions as a negative regulator of neurite outgrowth and inducer of neuronal apoptosis. J Cell Biol 2006; 175: 209-215. (Pubitemid 44631415)
61. Clardy SL, Wang X, Zhao W, Liu W, Chase GA, Beard JL, True Felt B, Connor JR: Acute and chronic effects of developmental iron deficiency on mRNA expression patterns in the brain. J Neural Transm Suppl 2006; 71: 173-196. (Pubitemid 351412119)
62. Brunette KE, Tran PV, Wobken JD, Carlson ES, Georgieff MK: Gestational and neonatal iron deficiency alters apical dendrite structure of CA1 pyramidal neurons in adult rat hippocampus. Dev Neurosci 2010; 32: 238-248.
63. Courchesne E, Karns CM, Davis HR, Ziccardi R, Carper RA, Tigue ZD, Chisum HJ, Moses P, Pierce K, Lord C, Lincoln AJ, Pizzo S, Schreibman L, Haas RH, Akshoomoff NA, Courchesne RY: Unusual brain growth patterns in early life in patients with autistic disorder: an MRI study. Neurology 2001; 57: 245-254. (Pubitemid 32667357)
64. Duce JA, Tsatsanis A, Cater MA, James SA, Robb E, Wikhe K, Leong SL, Perez K, Johanssen T, Greenough MA, Cho HH, Galatis D, Moir RD, Masters CL, McLean C, Tanzi RE, Cappai R, Barnham KJ, Ciccotosto GD, Rogers JT, Bush AI: Iron-export ferroxidase activity of beta-amyloid precursor protein is inhibited by zinc in Alzheimer's disease. Cell 2010; 142: 857-867.
65. Lei P, Ayton S, Finkelstein DI, Spoerri L, Ciccotosto GD, Wright DK, Wong BX, Adlard PA, Cherny RA, Lam LQ, Roberts BR, Volitakis I, Egan GF, McLean CA, Cappai R, Duce JA, Bush AI: Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export. Nat Med 2012; 18: 291-295.
66. Rossner S, Ueberham U, Schliebs R, Perez-Polo JR, Bigl V: The regulation of amyloid precursor protein metabolism by cholinergic mechanisms and neurotrophin receptor signaling. Prog Neurobiol 1998; 56: 541-569. (Pubitemid 28407571)
67. Haass C, Hung AY, Selkoe DJ: Processing of beta-amyloid precursor protein in microglia and astrocytes favors an internal localization over constitutive secretion. J Neurosci 1991; 11: 3783-3793.
68. Hung AY, Koo EH, Haass C, Selkoe DJ: Increased expression of beta-amyloid precursor protein during neuronal differentiation is not accompanied by secretory cleavage. Proc Natl Acad Sci USA 1992; 89: 9439-9443.
69. Kirazov E, Kirazov L, Bigl V, Schliebs R: Ontogenetic changes in protein level of amyloid precursor protein (APP) in growth cones and synaptosomes from rat brain and prenatal expression pattern of APP mRNA isoforms in developing rat embryo. Int J Dev Neurosci 2001; 19: 287-296. (Pubitemid 32405348)
70. Sokol DK, Chen D, Farlow MR, Dunn DW, Maloney B, Zimmer JA, Lahiri DK: High levels of Alzheimer beta-amyloid precursor protein (APP) in children with severely autistic behavior and aggression. J Child Neurol 2006; 21: 444-449. (Pubitemid 44069791)
71. Ray B, Long JM, Sokol DK, Lahiri DK: Increased secreted amyloid precursor proteinalpha (sAPPalpha) in severe autism: proposal of a specific, anabolic pathway and putative biomarker. PLoS One 2011; 6:e20405.
72. Sokol DK, Maloney B, Long JM, Ray B, Lahiri DK: Autism, Alzheimer disease, and fragile X: APP, FMRP, and mGluR5 are molecular links. Neurology 2011; 76: 1344-1352.
73. Connor JR, Menzies SL, St Martin SM, Mufson EJ: A histochemical study of iron, transferrin, and ferritin in Alzheimer's diseased brains. J Neurosci Res 1992; 31: 75-83.
74. Alizadeh BZ, Njajou OT, Millan MR, Hofman A, Breteler MM, van Duijn CM: HFE variants, APOE and Alzheimer's disease: findings from the population-based Rotterdam study. Neurobiol Aging 2009; 30: 330-332.
75. Pankov R, Yamada KM: Fibronectin at a glance. J Cell Sci 2002; 115: 3861-3863. (Pubitemid 35256486)
76. Blystone SD, Graham IL, Lindberg FP, Brown EJ: Integrin alpha v beta 3 differentially regulates adhesive and phagocytic functions of the fibronectin receptor alpha 5 beta 1. J Cell Biol 1994; 127: 1129-1137.
77. Lindbom L, Werr J: Integrin-dependent neutrophil migration in extravascular tissue. Semin Immunol 2002; 14: 115-121. (Pubitemid 34879387)
78. Porcionatto MA: The extracellular matrix provides directional cues for neuronal migration during cerebellar development. Braz J Med Biol Res 2006; 39: 313-320. (Pubitemid 43349465)
79. Gardiner NJ: Integrins and the extracellular matrix: key mediators of development and regeneration of the sensory nervous system. Dev Neurobiol 2011; 71: 1054-1072.
80. Beard JL, Felt B, Schallert T, Burhans M, Connor JR, Georgieff MK: Moderate iron deficiency in infancy: biology and behavior in young rats. Behav Brain Res 2006; 170: 224-232.